Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,956 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

NCT06105021

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • USC Norris Comprehensive Los Angeles, California, United States
  • University of California Los Angeles Department of Medicine Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View Trial Details
Active, Not Recruiting

Evaluation of a New Invitation Procedure to the French Organized Colorectal Cancer Screening Program

NCT05589675

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Regional Cancer Screening Coordinating Centre, Ardennes site Charleville-Mézières, Ardennes, France
  • Regional Cancer Screening Coordinating Centre, Meurthe-et-Moselle Site Nancy, Meurthe-et-Moselle, France
  • Regional Cancer Screening Coordinating Centre, Moselle Site Metz, Moselle, France
View Trial Details
Active, Not Recruiting

First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer

NCT06398743

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Tel Aviv Sourasky Medical Center Tel Aviv Yaffo, Central District, Israel
  • Hillel Yaffe Medical Center Hadera, North, Israel
  • Soroka University Medical Center Beersheba, Southern District, Israel
  • HaEmek Medical Center Afula, Israel
View all 22 locations
View Trial Details
Active, Not Recruiting

Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer

NCT04922853

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Genecast Biotechnology Co., Ltd Wuxi, Jiangsu, China
  • the Third People'S Hospital of Chengdu Chengdu, Sichuan, China
  • West China Hospital Chengdu, Sichuan, China
  • The Third Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China
View Trial Details

Related conditions